Figures computed from official regulatory filings — .
Statistical track record
FreeWin rates and median returns are available with a free account (5 insiders/month).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Details | |
|---|---|---|---|---|
Evommune, Inc.Listing unverified | Buy | $17.4K | SEC | |
Evommune, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
Evommune, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
Evommune, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
Evommune, Inc.Listing unverified | Other | — | SEC | |
Evommune, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
Evommune, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
Evommune, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
Evommune, Inc.Listing unverified | Other | — | SEC | |
Evommune, Inc.Listing unverified | Other | — | SEC | |
Evommune, Inc.Listing unverified | Other | — | SEC | |
Evommune, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
Evommune, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
Evommune, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
Evommune, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
Inozyme Pharma, Inc.Listing unverified | Other | $11.7M | SEC | |
Inozyme Pharma, Inc.Listing unverified | Other | $6.3M | SEC | |
Rallybio CorpListing on record | AwardD (derivative) | — | SEC | |
Rallybio CorpListing on record | AwardD (derivative) | $51.5K | SEC | |
Inozyme Pharma, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
Rallybio CorpListing on record | AwardD (derivative) | — | SEC | |
Inozyme Pharma, Inc.Listing unverified | Buy | $571.4K | SEC | |
Inozyme Pharma, Inc.Listing unverified | Buy | $3.4M | SEC | |
Inozyme Pharma, Inc.Listing unverified | AwardD (derivative) | — | SEC | |
Rallybio CorpListing on record | AwardD (derivative) | — | SEC |